201 related articles for article (PubMed ID: 31586052)
1. De novo identification of essential protein domains from CRISPR-Cas9 tiling-sgRNA knockout screens.
He W; Zhang L; Villarreal OD; Fu R; Bedford E; Dou J; Patel AY; Bedford MT; Shi X; Chen T; Bartholomew B; Xu H
Nat Commun; 2019 Oct; 10(1):4541. PubMed ID: 31586052
[TBL] [Abstract][Full Text] [Related]
2. sgRNA Sequence Motifs Blocking Efficient CRISPR/Cas9-Mediated Gene Editing.
Graf R; Li X; Chu VT; Rajewsky K
Cell Rep; 2019 Jan; 26(5):1098-1103.e3. PubMed ID: 30699341
[TBL] [Abstract][Full Text] [Related]
3. Sequence determinants of improved CRISPR sgRNA design.
Xu H; Xiao T; Chen CH; Li W; Meyer CA; Wu Q; Wu D; Cong L; Zhang F; Liu JS; Brown M; Liu XS
Genome Res; 2015 Aug; 25(8):1147-57. PubMed ID: 26063738
[TBL] [Abstract][Full Text] [Related]
4. CRISPR/Cas9-mediated gene knockout is insensitive to target copy number but is dependent on guide RNA potency and Cas9/sgRNA threshold expression level.
Yuen G; Khan FJ; Gao S; Stommel JM; Batchelor E; Wu X; Luo J
Nucleic Acids Res; 2017 Nov; 45(20):12039-12053. PubMed ID: 29036671
[TBL] [Abstract][Full Text] [Related]
5. BRD9 defines a SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors.
Wang X; Wang S; Troisi EC; Howard TP; Haswell JR; Wolf BK; Hawk WH; Ramos P; Oberlick EM; Tzvetkov EP; Ross A; Vazquez F; Hahn WC; Park PJ; Roberts CWM
Nat Commun; 2019 Apr; 10(1):1881. PubMed ID: 31015438
[TBL] [Abstract][Full Text] [Related]
6. CRISPR Screens Provide a Comprehensive Assessment of Cancer Vulnerabilities but Generate False-Positive Hits for Highly Amplified Genomic Regions.
Munoz DM; Cassiani PJ; Li L; Billy E; Korn JM; Jones MD; Golji J; Ruddy DA; Yu K; McAllister G; DeWeck A; Abramowski D; Wan J; Shirley MD; Neshat SY; Rakiec D; de Beaumont R; Weber O; Kauffmann A; McDonald ER; Keen N; Hofmann F; Sellers WR; Schmelzle T; Stegmeier F; Schlabach MR
Cancer Discov; 2016 Aug; 6(8):900-13. PubMed ID: 27260157
[TBL] [Abstract][Full Text] [Related]
7. Identification of oncogenic driver mutations by genome-wide CRISPR-Cas9 dropout screening.
Kiessling MK; Schuierer S; Stertz S; Beibel M; Bergling S; Knehr J; Carbone W; de Vallière C; Tchinda J; Bouwmeester T; Seuwen K; Rogler G; Roma G
BMC Genomics; 2016 Sep; 17(1):723. PubMed ID: 27613601
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatic and cell-based tools for pooled CRISPR knockout screening in mosquitos.
Viswanatha R; Mameli E; Rodiger J; Merckaert P; Feitosa-Suntheimer F; Colpitts TM; Mohr SE; Hu Y; Perrimon N
Nat Commun; 2021 Nov; 12(1):6825. PubMed ID: 34819517
[TBL] [Abstract][Full Text] [Related]
9. SliceIt: A genome-wide resource and visualization tool to design CRISPR/Cas9 screens for editing protein-RNA interaction sites in the human genome.
Vemuri S; Srivastava R; Mir Q; Hashemikhabir S; Dong XC; Janga SC
Methods; 2020 Jun; 178():104-113. PubMed ID: 31494246
[TBL] [Abstract][Full Text] [Related]
10. sgRNA Scorer 2.0: A Species-Independent Model To Predict CRISPR/Cas9 Activity.
Chari R; Yeo NC; Chavez A; Church GM
ACS Synth Biol; 2017 May; 6(5):902-904. PubMed ID: 28146356
[TBL] [Abstract][Full Text] [Related]
11. MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens.
Li W; Xu H; Xiao T; Cong L; Love MI; Zhang F; Irizarry RA; Liu JS; Brown M; Liu XS
Genome Biol; 2014; 15(12):554. PubMed ID: 25476604
[TBL] [Abstract][Full Text] [Related]
12. Pooled Lentiviral CRISPR-Cas9 Screens for Functional Genomics in Mammalian Cells.
Aregger M; Chandrashekhar M; Tong AHY; Chan K; Moffat J
Methods Mol Biol; 2019; 1869():169-188. PubMed ID: 30324523
[TBL] [Abstract][Full Text] [Related]
13. CSC software corrects off-target mediated gRNA depletion in CRISPR-Cas9 essentiality screens.
Perez AR; Sala L; Perez RK; Vidigal JA
Nat Commun; 2021 Nov; 12(1):6461. PubMed ID: 34753924
[TBL] [Abstract][Full Text] [Related]
14. Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells.
Meyers RM; Bryan JG; McFarland JM; Weir BA; Sizemore AE; Xu H; Dharia NV; Montgomery PG; Cowley GS; Pantel S; Goodale A; Lee Y; Ali LD; Jiang G; Lubonja R; Harrington WF; Strickland M; Wu T; Hawes DC; Zhivich VA; Wyatt MR; Kalani Z; Chang JJ; Okamoto M; Stegmaier K; Golub TR; Boehm JS; Vazquez F; Root DE; Hahn WC; Tsherniak A
Nat Genet; 2017 Dec; 49(12):1779-1784. PubMed ID: 29083409
[TBL] [Abstract][Full Text] [Related]
15. CRISPR library designer (CLD): software for multispecies design of single guide RNA libraries.
Heigwer F; Zhan T; Breinig M; Winter J; Brügemann D; Leible S; Boutros M
Genome Biol; 2016 Mar; 17():55. PubMed ID: 27013184
[TBL] [Abstract][Full Text] [Related]
16. [sgRNA design for the CRISPR/Cas9 system and evaluation of its off-target effects].
Xie SS; Zhang Y; Zhang LS; Li GL; Zhao CZ; Ni P; Zhao SH
Yi Chuan; 2015 Nov; 37(11):1125-36. PubMed ID: 26582526
[TBL] [Abstract][Full Text] [Related]
17. Unsupervised correction of gene-independent cell responses to CRISPR-Cas9 targeting.
Iorio F; Behan FM; Gonçalves E; Bhosle SG; Chen E; Shepherd R; Beaver C; Ansari R; Pooley R; Wilkinson P; Harper S; Butler AP; Stronach EA; Saez-Rodriguez J; Yusa K; Garnett MJ
BMC Genomics; 2018 Aug; 19(1):604. PubMed ID: 30103702
[TBL] [Abstract][Full Text] [Related]
18. Evaluation and Design of Genome-Wide CRISPR/SpCas9 Knockout Screens.
Hart T; Tong AHY; Chan K; Van Leeuwen J; Seetharaman A; Aregger M; Chandrashekhar M; Hustedt N; Seth S; Noonan A; Habsid A; Sizova O; Nedyalkova L; Climie R; Tworzyanski L; Lawson K; Sartori MA; Alibeh S; Tieu D; Masud S; Mero P; Weiss A; Brown KR; Usaj M; Billmann M; Rahman M; Constanzo M; Myers CL; Andrews BJ; Boone C; Durocher D; Moffat J
G3 (Bethesda); 2017 Aug; 7(8):2719-2727. PubMed ID: 28655737
[TBL] [Abstract][Full Text] [Related]
19. Identifying synthetic lethal targets using CRISPR/Cas9 system.
Dhanjal JK; Radhakrishnan N; Sundar D
Methods; 2017 Dec; 131():66-73. PubMed ID: 28710008
[TBL] [Abstract][Full Text] [Related]
20. Design, execution, and analysis of pooled in vitro CRISPR/Cas9 screens.
Miles LA; Garippa RJ; Poirier JT
FEBS J; 2016 Sep; 283(17):3170-80. PubMed ID: 27250066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
